On December 5, 2017, the Federal Circuit heard oral argument in Momenta Pharmaceuticals, Inc. v. Bristol-Myers Squibb Company, 17-1694. Momenta is appealing a PTAB decision upholding the validity of ...

In Bristol-Myers Squibb Co. v. Teva Pharmaceuticals USA, Inc., the Federal Circuit affirmed the district court’s finding that BMS’s Baraclude® patent is invalid as obvious. In so doing, the court gave ...

Analog Devices Inc. ADI recently announced that the company’s precision battery management system (BMS) integrated circuits (ICs) will be used by Rimac Automobili in its electric vehicle systems. The ...